Annual General Meeting 2026

Asker Healthcare Group AB (publ), Reg. No. 559184-9848 (“Asker” or the “Company”), with its registered office in Danderyd, gives notice of the Annual General Meeting to be held on 7 May 2026 at 13.30 CEST at Industrisalen, Näringslivets hus, Storgatan 19, SE-114 51 Stockholm, Sweden. Registration starts at 13.00 CEST.

 Right to participate in the Annual General Meeting and notice of participation

Participation in the Annual General Meeting at the venue

A shareholder who wishes to participate in the Annual General Meeting at the venue, in person or represented by a proxy, must:

(i) be recorded as a shareholder in the share register maintained by Euroclear Sweden AB (“Euroclear”) relating to the circumstances on Tuesday 28 April 2026, and

(ii) no later than Thursday 30 April 2026 give notice by post to Asker Healthcare Group AB (publ), c/o Euroclear Sweden AB, P.O. Box 191, SE-101 23 Stockholm, Sweden, via e-mail to [email protected], or by telephone +46 8 402 91 33. When providing such notice, the shareholder shall state name, personal or corporate registration number, address, telephone number and the number of any accompanying assistant(s) (maximum two assistants) as well as information about any proxy.

If a shareholder is represented by proxy, a written, dated proxy for the representative must be issued. A proxy form is available on the Company’s website, www.asker.com. If the proxy is issued by a legal entity, a certificate of registration or equivalent certificate of authority should be enclosed. To facilitate the registration at the Annual General Meeting, the proxy and the certificate of registration or equivalent certificate of authority should be sent to the Company as set out above so that it is received no later than Wednesday 6 May 2026.

Participation by voting in advance

A shareholder who wishes to participate in the Annual General Meeting by voting in advance must (i) be recorded as a shareholder in the share register maintained by Euroclear relating to the circumstances on Tuesday 28 April 2026, and (ii) give notice no later than Thursday 30 April 2026, by casting its advance vote in accordance with the instructions below so that the advance vote is received by the Company no later than on that day.

A shareholder who wishes to participate in the Annual General Meeting at the venue in person or represented by a proxy must give notice thereof in accordance with what is set out under Participation in the Annual General Meeting at the venue above. This means that a notification by advance vote is not sufficient for a person who wishes to participate at the venue.

A special form shall be used when advance voting. The advance voting form is available on the Company’s website www.asker.com. A completed and signed form may be submitted by post to Asker Healthcare Group AB (publ), c/o Euroclear Sweden AB, P.O. Box 191, SE-101 23 Stockholm, Sweden or via e-mail to [email protected]. The completed form shall be received by the Company not later than Thursday 30 April 2026. Shareholders who are natural persons may also cast their votes electronically through BankID verification via Euroclear’s website, https://www.euroclear.com/sweden/generalmeetings/. The shareholder may not provide special instructions or conditions in the voting form. If so, the vote (i.e. the advance vote in its entirety) is invalid. Further instructions and conditions are included in the form for advance voting.

If a shareholder votes by proxy, a written and dated proxy shall be enclosed to the advance voting form. A proxy form is available on the Company’s website www.asker.com. If the shareholder is a legal entity, a certificate of registration or equivalent certificate of authority should be enclosed. If a shareholder has voted in advance and then attends the Annual General Meeting in person or through a proxy, the advance vote is still valid except to the extent the shareholder participates in a voting procedure at the Annual General Meeting or otherwise withdraws its cast advance vote. If the shareholder chooses to participate in a voting at the Annual General Meeting, the vote cast will replace the advance vote with regard to the relevant item on the agenda.

Nominee-registered shares

To be entitled to participate in the Annual General Meeting, a shareholder whose shares are held in the name of a nominee must, in addition to providing notification of participation, register its shares in its own name so that the shareholder is recorded in the share register relating to the circumstances on Tuesday 28 April 2026. Such re-registration may be temporary (so-called voting right registration) and is requested from the nominee in accordance with the nominee’s procedures and in such time in advance as the nominee determines. Voting right registrations completed by the nominee not later than Thursday 30 April 2026 are taken into account when preparing the share register.

Proposed agenda

1. Opening of the Annual General Meeting
2. Election of chairperson of the Annual General Meeting
3. Preparation and approval of the voting list
4. Approval of the agenda
5. Election of one or two persons to approve the minutes
6. Determination of whether the Annual General Meeting has been duly convened
7. Presentation by the CEO
8. Presentation of the annual report and the auditor’s report, as well as the consolidated annual report and the consolidated auditor’s report
9. Resolution regarding the adoption of the profit and loss statement and the balance sheet, as well as the consolidated profit and loss statement and the consolidated balance sheet
10. Resolution regarding allocation of the Company’s profit or loss in accordance with the adopted balance sheet
11. Resolution regarding discharge from liability of the members of the Board of Directors and the CEO
12. Resolution on number of members of the Board of Directors and auditors
13. Resolution on fees for members of the Board of Directors and auditors
14. Election of members of the Board of Directors, Chair of the Board and auditors
15. Resolution on approval of the Board of Directors’ remuneration report
16. Resolution to amend the instructions for the Nomination Committee
17. Proposal to resolve to adopt a long-term performance-based investment share program:
    (a) resolution to adopt a long-term performance-based investment share program
    (b) resolution on authorisation for the Board of Directors to issue class C shares, repurchase issued class C shares and to transfer own ordinary shares
    (c) resolution on equity swap agreement with a third party
18. Resolution on authorisation for the Board of Directors to resolve on share issue, warrants and/or convertibles
19. Closing of the Annual General Meeting

The complete proposals can be found in the Notice and related documents below.

Related documents

Notice

Proxy form

Advance voting form

Proposals and motivated statement from the Nomination Committee

Instructions for the Nomination Committee

The Board of Directors’ statement under Chapter 19 Section 22 of the Swedish Companies Act

Read more about Corporate Governance